As of early 2025, the FDA had also received hundreds of adverse event reports linked to compounded semaglutide and compounded tirzepatide, many involving dosing errors from self-administration of multidose vials
The LEADER trial for liraglutide 1.8 mg demonstrated cardiovascular benefits in high-risk populations with type 2 diabetes
16 Compounded vs
Agent Pro-Tip: This program is designed strictly for weight loss
[76] Several clinical trials on additional GLP-1-based agents including triple agonists (Retatrutide), [77] oral formation (Orforglipron), [78] and combination therapy (CagriSema) are in the late phase of trials
With over 200 medically trained staff across 14 clinics, and proudly serving Ontario since 1992, were Canadas #1 provider of Botox, Juvederm, and CoolSculpting, and the leading provider of EMSCULPT NEO in Ontario